open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-03-11
Submitted: 2019-12-12
Accepted: 2020-01-27
Get Citation

Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin

J. Sadeghinezhad, I. Amrein
DOI: 10.5603/FM.a2020.0031
·
Pubmed: 32159839

open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-03-11
Submitted: 2019-12-12
Accepted: 2020-01-27

Abstract

Background: Oxaliplatin (OX) has been widely used for treatment of colorectal and other cancers. Adverse effect of OX and other anticancer agents on cognition have been reported, but studies on the effects of chemotherapy on brain structure are scarce. This study describes the morphometrical features of the hippocampus structures in rat following OX treatment using design-based stereological methods. Materials and methods: Ten male Wistar rats were randomized into two groups. The rats from OX group received 2.4 mg/kg OX in vehicle for five consecutive days every week for 2 weeks intraperitoneally (IP). Controls received vehicle only. Cavalieri 's method and the optical fractionator method were used for volume and neuron estimation, respectively. Results: Cavalieri 's method was used for to estimate volume and showed that the volume of the hippocampus was significantly decreased in OX group (31.84 ± 1.24 mm3) compared with the vehicle control group (36.95 ± 3.48 mm3). The optical fractionator method was used to estimate neuron number and showed that the number of neurons in dentate gyrus, cornu ammonis 1 and 3 in OX group (8.147 ± 2.84 × 105, 4.257 ±  0.59 × 105 and 2.133 ± 0.22 × 105, respectively) did not differ from  those of vehicle control group (7.36 ± 1.42 × 105, 3.521 ± 0.54  × 105 and 1.989 ± 0.46 × 105, respectively). Conclusions: These findings suggested that OX treatment induce loss of hippocampal volume without neuronal loss which might help to clarify the mechanism by which OX affects cognition and to improve preventive treatment strategies.

Abstract

Background: Oxaliplatin (OX) has been widely used for treatment of colorectal and other cancers. Adverse effect of OX and other anticancer agents on cognition have been reported, but studies on the effects of chemotherapy on brain structure are scarce. This study describes the morphometrical features of the hippocampus structures in rat following OX treatment using design-based stereological methods. Materials and methods: Ten male Wistar rats were randomized into two groups. The rats from OX group received 2.4 mg/kg OX in vehicle for five consecutive days every week for 2 weeks intraperitoneally (IP). Controls received vehicle only. Cavalieri 's method and the optical fractionator method were used for volume and neuron estimation, respectively. Results: Cavalieri 's method was used for to estimate volume and showed that the volume of the hippocampus was significantly decreased in OX group (31.84 ± 1.24 mm3) compared with the vehicle control group (36.95 ± 3.48 mm3). The optical fractionator method was used to estimate neuron number and showed that the number of neurons in dentate gyrus, cornu ammonis 1 and 3 in OX group (8.147 ± 2.84 × 105, 4.257 ±  0.59 × 105 and 2.133 ± 0.22 × 105, respectively) did not differ from  those of vehicle control group (7.36 ± 1.42 × 105, 3.521 ± 0.54  × 105 and 1.989 ± 0.46 × 105, respectively). Conclusions: These findings suggested that OX treatment induce loss of hippocampal volume without neuronal loss which might help to clarify the mechanism by which OX affects cognition and to improve preventive treatment strategies.

Get Citation

Keywords

stereology, hippocampus, oxaliplatin, chemotherapy, rat

About this article
Title

Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin

Journal

Folia Morphologica

Issue

Ahead of Print

Published online

2020-03-11

DOI

10.5603/FM.a2020.0031

Pubmed

32159839

Keywords

stereology
hippocampus
oxaliplatin
chemotherapy
rat

Authors

J. Sadeghinezhad
I. Amrein

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl